Stay updated on Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page.

Latest updates to the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page
- Check6 days agoChange DetectedAdministrative updates to the study record: new update dates posted on 2026-03-12 and 2026-03-13, replacing earlier dates 2026-03-05 and 2026-03-06.SummaryDifference0.1%

- Check13 days agoChange DetectedAdded entries for 2026-03-05 and 2026-03-06 with Revision: v3.4.3; older 2025 entries and Revision: v3.4.2 were removed.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2; no visible changes to page content.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision history updated from v3.4.0 to v3.4.1. No study details or other content were modified.SummaryDifference0.0%

- Check57 days agoChange DetectedThe label in the Study Record Dates changes from 'Last Update Posted (Estimated)' to 'Last Update Posted', a UI simplification that does not affect data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4; no substantive changes to the study details or page content were observed.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page.